Related Experiment Video
Updated: Jun 5, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Size-dependent activation of CAR-T cells
Qian Xiao1,2,3, Xinyan Zhang1, Liqun Tu2
1Department of Cell Biology, Yale School of Medicine, New Haven, CT 06520, USA.
Abstract:
As the targets of chimeric antigen receptor (CAR)-T cells expand to a variety of cancers, autoimmune diseases, viral infections, and fibrosis, there is an increasing demand for identifying new antigens and designing new CARs that can be effectively activated. However, the rational selection of antigens and the design of CARs are limited by a lack of knowledge regarding the molecular mechanism by which CARs are activated by antigens. Here, we present data supporting a "size exclusion" model explaining how antigen signals are transmitted across the plasma membrane to activate the intracellular domains of CARs. In this model, antigen engagement with CAR results in a narrow intermembrane space that physically excludes CD45, a bulky phosphatase, out of the CAR zone, thus favoring CAR phosphorylation by kinases, which further triggers downstream pathways leading to T cell activation. Aligned with this model, increasing the size of CAR extracellular domains diminished CAR-T activation both in vitro and in a mouse lymphoma model; membrane-proximal epitopes activated CAR-Ts better than membrane-distal epitopes. Moreover, increasing the size of CD45 by antibody conjugation enhanced the activation of CARs that recognize membrane-distal epitopes. Consistently, CAR-Ts expressing CD45RABC, the larger isoform, were activated to a higher level than those expressing a smaller isoform CD45RO. Together, our work revealed that CAR-T activation depends on the size difference between the CAR-antigen pair and CD45; the size of CAR, antigen, and CD45 can thus be targets for tuning CAR-T activation.
Insights
Chimeric antigen receptor (CAR)-T cell activation relies on a "size exclusion" mechanism. This model explains how antigen size and the phosphatase CD45 influence T cell signaling and activation efficacy.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Therapy
Background:
- Chimeric antigen receptor (CAR)-T cell therapy is expanding to new diseases, necessitating better antigen targeting and CAR design.
- Current CAR design is limited by incomplete understanding of antigen-mediated CAR activation mechanisms.
Purpose of the Study:
- To elucidate the molecular mechanism of CAR activation by antigens.
- To propose and validate a "size exclusion" model for CAR activation.
Main Methods:
- Investigated CAR activation using in vitro assays and a mouse lymphoma model.
- Manipulated the size of CAR extracellular domains and CD45 (a phosphatase).
- Compared CAR-T cell activation with different CAR isoforms and epitope binding sites.
Main Results:
- A "size exclusion" model was supported, where antigen engagement excludes CD45, promoting CAR phosphorylation and T cell activation.
- Larger CAR extracellular domains reduced CAR-T activation.
- Membrane-proximal epitopes were more effective than membrane-distal epitopes.
- Increasing CD45 size enhanced CAR activation for membrane-distal epitopes.
- Larger CD45 isoforms (CD45RABC) led to higher CAR-T activation than smaller isoforms (CD45RO).
Conclusions:
- CAR-T cell activation is critically dependent on the size difference between the CAR-antigen complex and CD45.
- CAR, antigen, and CD45 size are tunable parameters for optimizing CAR-T cell therapy efficacy.
More Related Videos
Related Concept Videos
Cell-mediated Immune Responses
Selectins
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

